Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Bexorg provides a technology platform for central nervous system drug discovery and development.
HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.
RNAV8 Bio is a stealth-mode company that focuses on engineering and designing large RNAs to treat chronic and acute, pre-cancerous diseases.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Duracyte is a biotechnology business that develops implantable "living pharmacy" devices.
Landmark Bio is a biotechnology industry.
Steer Bio is a biotechnology company that specializes in revitalizing cell-based medicines.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.
SynthX Center is a biomedical research center focused on developing drugs and health technologies.
Daré Bioscience is a biopharmaceutical company that develops and commercializes therapies for women's health.
InSilicoTrials provides in silico modeling and simulation tools that help researchers improve drug development using computational methods.
SecondWave Systems is an ultrasound stimulation platform.
Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.
Mission Mobile Medical provides mobile medical units at low costs.
Homeward is focused on improving access to high-quality, affordable primary and specialty care in rural communities.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Nura Health creates an all-inclusive precision medicine platform that speeds up endometriosis early detection and individualized care.
Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible.
34 Lives strives to reduce this statistic to zero by providing innovative technology and services for the kidney transplant process.
Advanced Research Projects Agency for Health has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Advanced Research Projects Agency for Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Artificial Intelligence (AI). The firm invests across 19 different industry categories.
Among tracked funding rounds, Every Cure received $60.0M in a Grant round. Advanced Research Projects Agency for Health's total known invested capital is $1.0B.
Advanced Research Projects Agency for Health's average investment size is $20.0M across its portfolio of 50 companies.
Recent Advanced Research Projects Agency for Health portfolio additions include Bexorg, HDT Bio, RNAV8 Bio, Trace Biosciences, ImmunoVec. These companies were founded in 2020 or later.